We are live on ! Find out more
GHA

GW Henssler & Associates Portfolio holdings

AUM $2.25B
1-Year Est. Return 19.46%
This Fund
S&P 500
This Quarter Est. Return
+3.83%
1 Year Est. Return
+19.46%
3 Year Est. Return
+62.37%
5 Year Est. Return
+80.78%
10 Year Est. Return
+246.91%
AUM
$1.1B
AUM Growth
+$13.3M
Cap. Flow
-$24.2M
Cap. Flow %
-2.19%
Top 10 Hldgs %
27.52%
Holding
243
New
37
Increased
59
Reduced
88
Closed
42

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$16.6M
2
MET icon
MetLife
MET
+$12.3M
3
TROW icon
T. Rowe Price
TROW
+$11M
4
SCHW
Charles Schwab
SCHW
+$10.8M
5
BLK icon
Blackrock
BLK
+$7.3M

Sector Composition

Rank Sector Weight
1 Healthcare 12.28%
2 Consumer Staples 11.92%
3 Technology 10.82%
4 Financials 9.16%
5 Energy 6.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FFIV icon
101
F5
FFIV
$22.7B
$600K 0.05%
4,120
-1,033
-20% -$155K
FBIN icon
102
Fortune Brands Innovations
FBIN
$6.06B
$593K 0.05%
12,148
BA icon
103
Boeing
BA
$185B
$579K 0.05%
1,590
-894
-36% -$326K
WKC icon
104
World Kinect Corp
WKC
$1.86B
$579K 0.05%
16,100
-21,031
-57% -$660K
DXC icon
105
DXC Technology
DXC
$1.73B
$574K 0.05%
+10,400
New +$602K
SCHD icon
106
Schwab US Dividend Equity ETF
SCHD
$106B
$568K 0.05%
32,094
+2,058
+7% +$36.2K
CGNX icon
107
Cognex
CGNX
$11.3B
$566K 0.05%
11,800
-7,539
-39% -$363K
VOO icon
108
Vanguard S&P 500 ETF
VOO
$1.03T
$564K 0.05%
2,094
+454
+28% +$120K
IMO icon
109
Imperial Oil
IMO
$60.4B
$551K 0.05%
+19,900
New +$558K
CHKP icon
110
Check Point Software Technologies
CHKP
$13.1B
$549K 0.05%
4,750
-4,200
-47% -$496K
DOX icon
111
Amdocs
DOX
$6.22B
$546K 0.05%
+8,800
New +$508K
LDOS icon
112
Leidos
LDOS
$17.3B
$543K 0.05%
+6,800
New +$497K
MET icon
113
MetLife
MET
$62.1B
$543K 0.05%
10,940
-261,355
-96% -$12.3M
CTXS
114
DELISTED
Citrix Systems Inc
CTXS
$540K 0.05%
+5,500
New +$540K
NTAP icon
115
NetApp
NTAP
$37.2B
$531K 0.05%
+8,600
New +$580K
WSM icon
116
Williams-Sonoma
WSM
$29.6B
$520K 0.05%
16,000
+1,788
+13% +$51.3K
AIVL icon
117
WisdomTree US AI Enhanced Value Fund
AIVL
$436M
$516K 0.05%
6,021
+466
+8% +$39.6K
OMC icon
118
Omnicom Group
OMC
$23.4B
$516K 0.05%
+6,300
New +$497K
CMI icon
119
Cummins
CMI
$88.7B
$514K 0.05%
+3,000
New +$491K
MSM icon
120
MSC Industrial Direct
MSM
$6.86B
$505K 0.05%
+6,800
New +$525K
DGRW icon
121
WisdomTree Trust WisdomTree US Quality Dividend Growth Fund
DGRW
$17.3B
$496K 0.04%
11,354
+1,554
+16% +$67.3K
RHI icon
122
Robert Half
RHI
$4.37B
$496K 0.04%
+8,700
New +$519K
CBRL icon
123
Cracker Barrel
CBRL
$1.29B
$488K 0.04%
2,859
+39
+1% +$6.39K
AYI icon
124
Acuity Brands
AYI
$10.8B
$483K 0.04%
3,500
-530
-13% -$72.9K
KTB icon
125
Kontoor Brands
KTB
$4.26B
$483K 0.04%
+17,247
New +$513K

Similar funds

GW Henssler & Associates's Q2 2019 Portfolio in Review

As of Q2 2019, GW Henssler & Associates held 243 positions worth $1.1B, up 1.2% from $1.09B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

GW Henssler & Associates's Q2 2019 filing shows 37 new, 59 increased, 88 reduced and 42 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 27,739 shares worth $8.68M. The largest sale was Celgene Corp, an estimated $16.6M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, down from 13% a quarter earlier, followed by Consumer Staples and Technology.

  • GW Henssler & Associates's largest Q2 2019 buy was Regeneron Pharmaceuticals: 27,739 shares worth $8.68M.
  • GW Henssler & Associates added most to State Street Utilities Select Sector SPDR ETF in Q2 2019, an estimated $11.5M increase.
  • GW Henssler & Associates's biggest Q2 2019 reduction was Celgene Corp, cutting an estimated $16.6M.
  • GW Henssler & Associates fully exited NIC Inc in Q2 2019, selling an estimated $1.2M.
  • GW Henssler & Associates's ten largest holdings make up 28% of its $1.1B portfolio in Q2 2019.
  • GW Henssler & Associates opened 37 new positions and closed 42 in Q2 2019.
  • GW Henssler & Associates's portfolio value rose 1.2% quarter-over-quarter to $1.1B.

Based on GW Henssler & Associates's 13F filing for Q2 2019, filed 5 Aug 2019.